To assess the efficacy and safety of pharmacological interventions for providing symptomatic relief or a disease-modifying effect on respiratory function in people with ALS.
This is a protocol.
Pharmacological interventions for improving respiratory function in amyotrophic lateral sclerosis
You may also be interested in:
- Managing symptoms in motor neuron disease
- Minocycline for amyotrophic lateral sclerosis or motor neuron disease
- Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease (ALS/MND)
- Treatment for spasticity (muscle tightness and spasm) in people with amyotrophic lateral sclerosis/motor neuron disease
- Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis, also known as motor neuron disease
Health topics: